title: Calcium binding in the pore of L-type calcium channels modulates high affinity dihydropyridine binding.
abstract: The pore-forming alpha 1 subunit of L-type voltage-gated Ca2+ channels contains a Ca(2+)-binding site that is allosterically coupled to the receptor site for dihydropyridine (DHP) Ca2+ antagonists. Site-directed mutations of conserved Phe and Glu residues in the pore-lining SS1/SS2 segments greatly reduced Ca2+ enhancement of DHP binding. Substitution of Phe-1013 in the alpha 1 subunit from rabbit skeletal muscle (alpha 1S) with Gly (F1013G) as in DHP-insensitive Ca2+ channels caused a 4-fold decrease in sensitivity to Ca2+. Mutation of the Ca(2+)-binding residues Glu-1014 in domain III and Glu-1323 in domain IV to Gln (E1014Q and E1323Q) caused 11- and 35-fold decreases in sensitivity to Ca2+, respectively, as well as decreases in the maximal DHP binding affinities attained at optimal concentrations of Ca2+. DHP binding to the charge-reversal mutation, E1014K, had no sensitivity to Ca2+. Our results demonstrate that high affinity Ca2+ binding to the Glu residues in the SS1/SS2 segments of domains III and IV of alpha 1S stabilizes the DHP receptor site in its high affinity state. We propose a three-state model in which the affinity for DHPs is dependent on the presence of 0, 1, or 2 bound Ca2+ ions at sites in the pore.
authors.affiliation: Department of Pharmacology, School of Medicine, University of Washington, Seattle 98195, USA.
authors.forename: B Z
authors.initials: BZ
authors.lastname: Peterson
authors.forename: W A
authors.initials: WA
authors.lastname: Catterall
mesh_terms: D000595:Amino Acid Sequence; D001464:Barium / Q000494:pharmacology; D001665:Binding Sites; D002104:Cadmium / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000235:genetics / Q000378:metabolism*; D020746:Calcium Channels, L-Type; D004095:Dihydropyridines / Q000378:metabolism*; D018698:Glutamic Acid / Q000378:metabolism; D015640:Ion Channel Gating; D008566:Membranes / Q000378:metabolism; D008954:Models, Biological; D008956:Models, Chemical; D008969:Molecular Sequence Data; D009154:Mutation; D011487:Protein Conformation; D011869:Radioligand Assay
chemical_list: D015220:Calcium Channels; D020746:Calcium Channels, L-Type; D004095:Dihydropyridines; D002104:Cadmium; D001464:Barium; D018698:Glutamic Acid; C038806:1,4-dihydropyridine; D002118:Calcium